Medik8 owns the evidence-led buyer.
The equity stops at the price tag.

A Gutsy brand audit of Medik8 across product, pack, listing, digital and campaign touchpoints, scored by three AI-lookalike audiences against 73 prestige beauty brands and 257 skincare listings.

Gutsy Intelligence

The Ask

How do North American audiences read Medik8, and what should the team fix first?

Gutsy scored Medik8's brand record, its Liquid Peptides listing and its CSA Philosophy platform through three AI-lookalike audiences, then benchmarked each read against the full scored field. Perception, not aspiration, drives every score.

Dataset Scope

73 prestige beauty brands benchmarked 257 skincare listings scored 126 product brands 20 channels 1 Medik8 SKU · 1 scored campaign 3 audiences · 8 brand variables · 8 product lenses

IN SCOPE

Seven consumer-visible touchpoints

Product (Liquid Peptides formula), pack (30 mL glass dropper and carton), the amazon.com listing and its price, digital and social reach, corporate press, loyalty, and the CSA Philosophy brand platform. Stated identity is taken verbatim from medik8.com.

OUT OF SCOPE

What this audit does not cover

Financial brand value and employer brand (not consumer perception); the clinic and professional channel; UK and EU markets; customer service. Gutsy holds one Medik8 SKU, so product reads rest on Liquid Peptides alone.

Sources: Gutsy brand intelligence (Medik8 record), Gutsy product intelligence (skin care category listings), Gutsy campaign intelligence. Channels: amazon.com, amazon.ca, walmart.com and 17 brand web stores.

The Audience

Three audiences, three very different reads of prestige skincare

Tech Titans buy on proof; the other two buy on familiarity and value. Each audience's top skincare buy beside Medik8, on Gutsy purchase intent (out of 10).

Tech Titans

AI-lookalike audience · innovation-first professionals

Buys on: innovation, data-backed efficacy. Skeptical of: claims without data.

Riversol Vitamin C SerumTop skincare buy · $39.95

8.03

Medik8 Liquid Peptides#13 of 257 · $68

7.78

"A quantified 30% peptide complex from a brand that makes its own formulas. $68 is within what I spend on actives."Tech Titans on Liquid Peptides · Gutsy panel

Cul-de-Sac Comfort

AI-lookalike audience · practical suburban families

Buys on: trusted mainstream brands, value. Skeptical of: unjustified premiums.

CeraVe Hydrating CleanserTop skincare buy · $13.68

7.67

Medik8 Liquid Peptides#157 of 257 · $68

2.52

"The formula looks serious, but $68 an ounce from a brand I don't know is hard to justify against a $20 drugstore serum."Cul-de-Sac Comfort on Liquid Peptides · Gutsy panel

Blue Collar Backbone

AI-lookalike audience · value-first working households

Buys on: honest value, heritage. Skeptical of: premium lifestyle branding.

Vaseline Men 3in1 LotionTop skincare buy · $20.99

7.03

Medik8 Liquid Peptides#206 of 257 · $68

1.26

"Nearly seventy dollars for a dropper of peptides. Nothing on that box says it's made for someone like me."Blue Collar Backbone on Liquid Peptides · Gutsy panel

The Headline Answer

#1 of 73

Tech Titans rank Medik8 first of 73 prestige beauty brands. Cul-de-Sac Comfort place it fifth; Blue Collar Backbone, 27th.

Equity verdicts: Tech Titans Strong (7.97 out of 10 across the eight Gutsy brand variables; field median 6.05). Cul-de-Sac Comfort Healthy (6.20; median 5.35), with trust ranked #2 of 73. Blue Collar Backbone Weak (4.99; median 4.82): at parity with a prestige field this audience rates low overall.

Executive Summary

Trust and clarity travel; price and distinctiveness do not

Brand-equity verdicts: Tech Titans Strong, Cul-de-Sac Comfort Healthy, Blue Collar Backbone Weak.

Perceived strengths

Trust leads everywhere

#1 of 73 with Tech Titans (8.20), #2 with Cul-de-Sac Comfort (6.66), #4 with Blue Collar Backbone (5.86).

A routine people can decode

The CSA mission ("vitamin C plus sunscreen by day, vitamin A by night") scores 9.2 with Tech Titans, #1 of 73.

The formula is believed

Liquid Peptides scores 7.04 on product belief with Cul-de-Sac Comfort, #51 of 257, even where price fails.

Perceived gaps

Price-value

3.06 with Cul-de-Sac Comfort (#168 of 257) and 2.38 with Blue Collar Backbone.

A generic tagline

"Results Without Compromise" ranks #58 and #57 of 73 on distinctiveness with the two mainstream audiences.

Proof missing at the point of sale

The US listing carries no B Corp, UK-made or clinical-study claim; its only certification is "gluten free".

Prioritized actions

1. Put the proof on the listing

B Corp, UK in-house manufacture and study evidence on the amazon.com listing and carton.

2. Lead with outcomes

Open copy with the visible benefit, then the "30% complex" spec.

3. Lower the cost of a first try

A trial size or starter kit for mainstream buyers who score price-range fit at 2.1.

Source: Gutsy brand scoring (73-brand prestige beauty benchmark) and product scoring (257 skincare listings). Verdict bands on the eight-variable brand average: Strong 7.0+, Healthy 5.5 to 6.9, Stretched 5.0 to 5.4, Weak below 5.0.

Scope & Promise

Each audience holds Medik8 to a different promise

Tech Titans hold Medik8 to measurable results; the mainstream audiences hold it to a value case it has not yet made to them. Promises are synthesized from Gutsy audience scoring rationales. Hover the pills for who each audience is.

Audience	Stated promise, in their words	Implicit promise	Moments of truth
TT Tech Titans	"A clinical, data-guided routine that delivers visible results without a prescription."	Every claim has a number behind it: actives, percentages, independent studies.	Reading actives and concentration on the listing; 4.5 stars from 619 ratings; results after the first bottle.
CC Cul-de-Sac Comfort	"Professional-grade skincare that is safe and works."	Worth more than a trusted drugstore staple, and easy to find where they already shop.	The price check against $15 to $25 drugstore serums; looking for familiar reassurance marks.
BB Blue Collar Backbone	"Expensive cosmetic science made for someone else."	If it is for me, prove it plainly and price it honestly.	First sight of $68 for 1 fl oz; peer word of mouth; a plain-English benefit on the box.

Source: Gutsy brand and product scoring rationales for Medik8 and Liquid Peptides (amazon.com). Stated promises are written in audience voice as a synthesis of scoring rationales, not survey quotes.

Equity & Distinction · 1 of 2

Trust is the one dimension Medik8 leads with all three audiences

Trust ranks #1, #2 and #4 of 73. Scores out of 10; the line under each score is Medik8's rank in the 73-brand prestige beauty benchmark. Hover the pills for who each audience is.

Equity dimension	TT	CC	BB
Trust High confidence · clean controversy record and B Corp-backed promise integrity; mainstream audiences discount deal-focused press	8.20#1 of 73	6.66#2 of 73	5.86#4 of 73
Knowledge High confidence · the CSA mission reads as a protocol (9.2 with Tech Titans); clinical vocabulary costs clarity with Blue Collar Backbone	8.36#1 of 73	5.82#13 of 73	4.40#32 of 73
Esteem Medium confidence · CEW 2025 awards and Lab Notes earn regard with Tech Titans; "skintellectual" accolades read as niche to the others	8.33#1 of 73	4.77#22 of 73	3.07#34 of 73
Awareness Low confidence · 423K Instagram followers, 4.6K on YouTube; no recall or recognition survey in Gutsy's dataset	7.60#3 of 73	5.25#24 of 73	4.30#26 of 73

Field medians, Tech Titans / Cul-de-Sac Comfort / Blue Collar Backbone: Trust 5.82 / 5.48 / 5.12; Knowledge 6.22 / 5.06 / 4.22; Esteem 5.37 / 4.23 / 3.07; Awareness 5.80 / 4.45 / 3.95. Green = top 5 of 73; pink = below the field median. Dimension mapping on the methodology slide.

Equity & Distinction · 2 of 2

Mainstream buyers see Medik8 as neither different nor worth the premium

Differentiation falls to #42 and #53 of 73; premium-ness to #168 of 257 with Cul-de-Sac Comfort. Relevance and premium-ness are scored on the Liquid Peptides listing against all 257 scored skincare listings.

Equity dimension	TT	CC	BB
Differentiation High confidence · owns named concepts (#1 of 73 on concept ownership with Tech Titans); tagline and monochrome look read as category-standard to the others	7.60#10 of 73	5.24#42 of 73	3.88#53 of 73
Modernity Medium confidence · innovation language and the UK Innovation Centre score well; no modern loyalty programme on record (3.8 with Tech Titans)	6.74#3 of 73	4.92#8 of 73	3.72#19 of 73
Relevance Medium confidence · identity, basket and routine fit on one listing: identity fit 8.7 with Tech Titans, 2.7 and 1.2 with the others	8.67#22 of 257	3.70#117 of 257	1.47#184 of 257
Premium-ness Medium confidence · $68 for 30 mL reads as fair for a 30% peptide complex to Tech Titans (8.2) and steep to Cul-de-Sac Comfort (2.3)	8.15#12 of 257	3.06#168 of 257	2.38#114 of 257

Field medians, Tech Titans / Cul-de-Sac Comfort / Blue Collar Backbone: Differentiation 5.70 / 5.46 / 4.28; Modernity 4.54 / 4.14 / 3.50; Relevance 6.00 / 3.53 / 1.73; Premium-ness 6.25 / 3.48 / 2.26. Differentiation and Modernity: rank of 73 brands. Relevance and Premium-ness: rank of 257 listings, single-listing read.

Equity & Distinction

Medik8 leads the field with Tech Titans; SkinCeuticals travels further

SkinCeuticals pairs a near-Medik8 Tech Titans score (7.49) with the field's best Blue Collar Backbone score (5.77). Each dot is one of 73 brands; hover a dot for its scores.

Medik8 Travel to both Derma challengers Prestige and K-beauty Other brands

Medik8: furthest right on the evidence axis

7.97 with Tech Titans (#1 of 73); 4.99 with Blue Collar Backbone (#27), just above the 4.82 median.

SkinCeuticals, Kiehl's, iS Clinical travel

#1 to #3 with Blue Collar Backbone (5.77, 5.62, 5.51). Kiehl's gets there on 5.98 from Tech Titans.

Derma challengers sit close behind

Alastin (7.62) and Dr. Idriss (7.60) trail Medik8 on Tech Titans and lead it on Blue Collar Backbone (5.33, 5.23).

Prestige and K-beauty are mid-field

5.65 to 6.32 with Tech Titans; Tatcha and Sulwhasoo still outscore Medik8 with Blue Collar Backbone (5.29, 5.08).

Source: Gutsy brand scoring, 73 brands in the prestige beauty and cosmetic sector; axes show each brand's average across the eight Gutsy brand variables. Dashed lines are field medians (6.05, 4.82). With Cul-de-Sac Comfort, Medik8 scores 6.20, #5 of 73, behind SkinCeuticals, Alastin, Dr. Idriss and Sulwhasoo.

Equity & Distinction

Medik8's distinctive assets only count with Tech Titans

Owned concepts and promise integrity pass all three distinction tests with Tech Titans only. Distinctive = owned, relevant, hard to copy; Shared = parity; Lagging = a competitor owns it.

Attribute	Status	Owning competitor	Evidence (score, rank of 73)
TT Tech Titans
Owned routine concepts: CSA Philosophy, Crystal Retinal	Distinctive	None	Concept ownership 8.8, #1; mission concreteness 9.2, #1
Promise integrity and sourced messaging	Distinctive	None	Promise integrity 8.5, #1; provenance quality 9.5, #1
Tagline: "Results Without Compromise"	Lagging	Dr. Idriss (8.8)	Tagline distinctiveness 5.6, #31
CC Cul-de-Sac Comfort
Trustworthiness	Shared	Alastin (6.84)	Trust 6.66, #2
Differentiation	Lagging	Drunk Elephant (7.68)	Differentiation 5.24, #42; tagline 3.6, #58
BB Blue Collar Backbone
Clear routine mission	Shared	War Paint for Men (5.6)	Mission concreteness 4.8, #7: clear, but needs skincare literacy
Visual identity	Lagging	Drunk Elephant (7.8)	Visual distinctiveness 3.6, #62: reads as boutique-counter standard

Source: Gutsy brand-scoring subfactors for 73 prestige beauty brands, per audience. Owning competitor = highest-scoring brand on that measure for that audience.

Touchpoints & Action · 1 of 2

The formula convinces more than the price or the pack

Product belief is Medik8's strongest touchpoint with Cul-de-Sac Comfort (7.04, #51 of 257); price-value is its weakest (3.06, #168). Scored on the Liquid Peptides amazon.com listing: $68, 30 mL, 4.5 stars from 619 ratings.

Touchpoint	TT	CC	BB	Friction it creates
Product: the formulaProduct belief lens	Strong8.40#20 of 257	Strong7.04#51	Adequate4.59#115	Blue Collar Backbone doubt the "lifted, ageless" claims: overclaim skepticism 8.4.
Pack: glass dropper, white cartonVisual attention lens	Strong8.06#33 of 257	Adequate5.41#109	Weak3.96#159	No colour or icon cues: colour distinctiveness 4.8, icon recognition 3.2 on the pack read.
Listing copy and claimsClarity lens	Strong8.28#35 of 257	Adequate5.63#143	Weak3.74#213	Leads with "30% Complex" over outcomes; the only certification shown is "gluten free".
Price and value: $68Price-value lens	Strong8.15#12 of 257	Weak3.06#168	Weak2.38#114	$68 sits outside the price range Cul-de-Sac Comfort accept for daily skincare (2.1).

Source: Gutsy product scoring, Liquid Peptides (amazon.com) against 257 skincare listings. Delivery: Strong 7.0+, Adequate 4.5 to 6.9, Weak below 4.5; no touchpoint scored off-brand. Pack read from Gutsy's audience-neutral shelf-impact analysis.

Touchpoints & Action · 2 of 2

Brand channels speak to Tech Titans and leave mainstream buyers cold

The CSA Philosophy platform scores 7.7 on idea ownership with Tech Titans and 2.4 with Blue Collar Backbone. Brand-level touchpoints, scored on Medik8's brand record and its one scored campaign.

Touchpoint	TT	CC	BB	Friction it creates
CSA Philosophy platformIdea ownership	Strong7.70campaign	Weak3.40	Weak2.40	No recorded results: 0 on all four effectiveness-evidence measures. Product truth 2.6 with Blue Collar Backbone.
Corporate pressPress sentiment	Strong8.10#2 of 73	Adequate5.20#18	Weak3.40#48	All three recorded headlines are deal news: the L'Oréal stake and a private-equity award.
Digital and social reachAudience reach	Adequate6.80#9 of 73	Adequate5.10#22	Adequate4.80#30	Reach is Instagram-led (423K followers); YouTube 4.6K, X 2.2K.
Loyalty and CRMLoyalty modernity	Weak3.80#9 of 73	Weak3.00#14	Weak2.20#17	No consumer loyalty or regimen programme in the record.

Source: Gutsy brand scoring (73-brand benchmark) and Gutsy campaign scoring for CSA Philosophy (owned brand platform, 2009 onward). Ranks for the campaign are not shown: it is Medik8's only scored campaign. Delivery bands as on the previous slide.

Touchpoints & Action

Mainstream buyers accept the formula, not the $68 price

Riversol's $24.95 vitamin C serum scores 8.19 on price-value with Cul-de-Sac Comfort; Liquid Peptides scores 3.06. Price-value scores, facial serums in the 257-listing set.

Facial serum	TT	CC	BB
Medik8 Liquid Peptides$68 · 4.5 stars (619 ratings)	8.15	3.06	2.38
Riversol Vitamin C Serum$24.95 · 4.7 stars (74 ratings) · 60 mL	8.38	8.19	8.41
SkinMedica Retinol Serum 1.0$96 · 4.6 stars (2,848 ratings)	8.14	3.05	1.65
IOPE PDRN Caffeine Shot Serum$34.40 · 4.2 stars (552 ratings)	8.00	4.09	2.35
Drunk Elephant D-Bronzi Drops$39 · 4.6 stars (5,227 ratings)	7.62	3.62	1.70

Medik8 ranks #4, #13 and #7 of 23 facial serums on price-value with Tech Titans, Cul-de-Sac Comfort and Blue Collar Backbone. Green = 7.0+; pink = below 3.5. Source: Gutsy product scoring, amazon.com listings.

Perception Gaps

Medik8's strongest proof points never reach the US shopper

Stated identity is taken verbatim from medik8.com; perception from Gutsy audience scoring. Three gaps, one per type.

Says X, heard as Y: the tagline

"Results Without Compromise" is meant as a performance promise. Cul-de-Sac Comfort and Blue Collar Backbone hear generic prestige rhetoric: tagline distinctiveness 3.6 and 3.0, #58 and #57 of 73. Even Tech Titans want more specificity (6.2).

Intended, not heard: UK-made and B Corp

"Meticulously Made by Us in the UK" and B Corp certification lead Medik8's own messaging. The amazon.com listing carries neither: no sustainability claim, no country of origin, and "gluten free" as its only certification. Certification signal scores 6.2, 3.6 and 2.8.

Earned, not intended: deal-news reputation

All three recorded headlines cover the L'Oréal stake and a private-equity award. Press sentiment falls from 8.1 with Tech Titans to 5.2 and 3.4; Blue Collar Backbone read it as corporate markups. No CEO is named on record: leadership continuity scores 4.8, 4.1 and 3.5.

Sources: Medik8 stated identity (medik8.com/pages/about-us, verbatim); Gutsy brand scoring and Liquid Peptides listing intelligence (amazon.com). Scores listed Tech Titans, Cul-de-Sac Comfort, Blue Collar Backbone.

Risks & Watch-outs

Price is the near-term risk; the ownership change is the slow one

Value-derm brands own the entry point

Riversol's $24.95 vitamin C serum scores 7.4 to 7.5 on values and trust with all three audiences. Liquid Peptides scores 7.66, 5.38 and 3.76.

Louder brands own differentiation

Drunk Elephant leads differentiation with both mainstream audiences (7.68, 7.36). Medik8's monochrome system ranks #46 and #62 of 73 on visual distinctiveness.

Sustainability read as theater

Blue Collar Backbone score eco theater 5.6 and virtue density 5.8 (#47 and #46 of 73): the B Corp badge reads as a price justification unless it carries numbers.

Ownership transition (a read)

L'Oréal LUXE took a majority stake in 2025. The data suggests the "made by us" independence story needs active protection: Blue Collar Backbone already score leadership stability 4.0.

Source: Gutsy brand scoring (73 brands) and product scoring (257 listings). Values-and-trust scores are for the listing; differentiation and greenwashing measures for the brand.

Recommendation

Fix proof and price at the point of sale before buying more reach

Do now

1. Put the proof on the listing and carton

Add B Corp, UK in-house manufacture and the independent-study claim to the amazon.com title, bullets and carton. Target: certification signal with Cul-de-Sac Comfort from 3.6 to 6+. Impact high · effort low · confidence high · owner: e-commerce with regulatory.

Do now

2. Lead with the outcome, then the spec

Open copy with the visible benefit before "30% Complex": benefit clarity is 4.7 and 3.5 with the mainstream audiences. Target: listing clarity with Cul-de-Sac Comfort above the 5.83 median (now 5.63). Impact medium · effort low · confidence high · owner: brand content.

Next quarter

3. Lower the cost of a first try

A trial size or CSA starter kit near the $25 to $40 serums that lead mainstream price-value. Cul-de-Sac Comfort score price-range fit 2.1, trial intent 2.2. Target: purchase intent above the 2.74 median (now 2.52). Impact high · effort medium · confidence medium · owner: commercial and product; needs pricing, supply and channel sign-off.

Next quarter

4. Make CSA Philosophy the headline and prove it

Medik8 owns its concepts (#1 of 73 with Tech Titans) but its tagline ranks #31. Lead with the CSA rule and publish results: the platform has no recorded effectiveness evidence. Target: tagline distinctiveness top 10. Impact medium · effort medium · confidence medium · owner: brand and insights.

Monitor

5. Shift press to science, name a spokesperson; hold Blue Collar Backbone as a watch audience

Move earned media from deal news to product and science news (press sentiment 5.2 with Cul-de-Sac Comfort). Blue Collar Backbone rate the whole prestige field low: do not chase them. Impact medium · effort low to medium · confidence medium · owner: communications.

Sources & Methodology

How this was built

Dataset: Brand benchmark of 73 brands in Gutsy's prestige beauty and cosmetic sector, each scored on 8 brand variables (40 subfactors) per audience. Product benchmark of all 257 scored listings in Gutsy's skin care category (126 brands; 20 channels: amazon.com 113, amazon.ca 29, walmart.com 1, 17 brand web stores 114), each scored on 8 lenses (92 subfactors). Medik8 has one listing in Gutsy: Liquid Peptides 1 fl oz, amazon.com. One scored Medik8 campaign: CSA Philosophy.

Scoring: Gutsy AI-lookalike audience simulation. Tech Titans, Cul-de-Sac Comfort and Blue Collar Backbone are scored separately and never averaged. Negative signals (controversy, generic drift, narrative gaps, greenwashing risk, overclaim skepticism) are inverted so a higher score always reads better. Audience quotes are written from Gutsy scoring rationales; they are not survey responses.

Framework: Brand-audit equity dimensions mapped to Gutsy measures: Trust = trust; Knowledge = clarity; Differentiation = differentiation; Modernity = innovation perception; Esteem = awards, thought leadership and press sentiment; Awareness = audience reach and sector standing; Relevance = identity, basket and routine fit on the hero listing; Premium-ness = the price-value lens on the hero listing. Verdicts on the eight-variable brand average: Strong 7.0+, Healthy 5.5 to 6.9, Stretched 5.0 to 5.4, Weak below 5.0.

Not assessed: Market size, share and sales (not in Gutsy's dataset); aided awareness; the rest of the Medik8 range; clinic channel; customer service; UK and EU perception. Tatcha, SkinCeuticals, Kiehl's, Dr. Idriss and Alastin are benchmarked at brand level only: Gutsy holds no scored listing for them in this category.

Pipeline: Gutsy intelligence pipeline.

Medik8 owns the evidence-led buyer.The equity stops at the price tag.

How do North American audiences read Medik8, and what should the team fix first?

Seven consumer-visible touchpoints

What this audit does not cover

Three audiences, three very different reads of prestige skincare

Tech Titans

Cul-de-Sac Comfort

Blue Collar Backbone

Trust and clarity travel; price and distinctiveness do not

Trust leads everywhere

A routine people can decode

The formula is believed

Price-value

A generic tagline

Proof missing at the point of sale

1. Put the proof on the listing

2. Lead with outcomes

3. Lower the cost of a first try

Each audience holds Medik8 to a different promise

Trust is the one dimension Medik8 leads with all three audiences

Mainstream buyers see Medik8 as neither different nor worth the premium

Medik8 leads the field with Tech Titans; SkinCeuticals travels further

Medik8: furthest right on the evidence axis

SkinCeuticals, Kiehl's, iS Clinical travel

Derma challengers sit close behind

Prestige and K-beauty are mid-field

Medik8's distinctive assets only count with Tech Titans

The formula convinces more than the price or the pack

Brand channels speak to Tech Titans and leave mainstream buyers cold

Mainstream buyers accept the formula, not the $68 price

Medik8's strongest proof points never reach the US shopper

Price is the near-term risk; the ownership change is the slow one

Fix proof and price at the point of sale before buying more reach

1. Put the proof on the listing and carton

2. Lead with the outcome, then the spec

3. Lower the cost of a first try

4. Make CSA Philosophy the headline and prove it

5. Shift press to science, name a spokesperson; hold Blue Collar Backbone as a watch audience

How this was built

Medik8 owns the evidence-led buyer.
The equity stops at the price tag.